1. The Adrenergic Nerve Network in Cancer
    Claire Magnon, 2021, Tumor Microenvironment CrossRef
  2. In vitro and in silico study on the effect of carvedilol and sorafenib alone and in combination on the growth and inflammatory response of melanoma cells
    Joanna Wawszczyk et al, 2023, Saudi Pharmaceutical Journal CrossRef
  3. Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
    Nabil V Sayour et al, 2024, European Heart Journal CrossRef
  4. Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
    Hatice Satilmis et al, 2023, The Journal of Pathology CrossRef
  5. Differential Free Intracellular Calcium Release by Class II Antiarrhythmics in Cancer Cell Lines
    Marta Reyes-Corral et al, 2019, Journal of Pharmacology and Experimental Therapeutics CrossRef
  6. Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells
    Fang Wang et al, 2018, Molecular Medicine Reports CrossRef
  7. Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer
    Madeleine B. Hopson et al, 2021, Breast Cancer Research and Treatment CrossRef
  8. Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma
    Xinwei Kuang et al, 2018, Oncotarget CrossRef
  9. Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease
    Jessica Castro de Vasconcelos et al, 2018, International Journal of Endocrinology CrossRef
  10. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
    Sachin G Nair et al, 2024, Clinical & Experimental Metastasis CrossRef
  11. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma
    Caroline Miho Shibuya et al, 2022, Archives of Oral Biology CrossRef
  12. The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
    José A. Carlos-Escalante et al, 2021, Frontiers in Oncology CrossRef
  13. Trial watch: beta-blockers in cancer therapy
    Killian Carnet Le Provost et al, 2023, OncoImmunology CrossRef
  14. Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics
    Yuchen Jin et al, 2020, Cancer Letters CrossRef
  15. Propranolol inhibits proliferation and induces apoptosis of hemangioma-derived endothelial cells via Akt pathway by down-regulating Ang-2 expression
    Bin Sun et al, 2020, Chemico-Biological Interactions CrossRef
  16. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade
    François Moisan et al, 2021, Proceedings of the National Academy of Sciences CrossRef
  17. The morphological analysis of anaplastic thyroid cancer cell line
    Hatice OZİSİK et al, 2022, Ege Tıp Dergisi CrossRef
  18. Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
    Laurentia Gales et al, 2022, Medicina CrossRef